Dimensional Fund Advisors’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84.5K Sell
36,053
-14,642
-29% -$35.4K ﹤0.01% 3133
2025
Q4
$121K Sell
50,695
-13,621
-21% -$33.6K ﹤0.01% 3132
2025
Q3
$171K Sell
64,316
-6,649
-9% -$19.7K ﹤0.01% 3141
2025
Q2
$210K Sell
70,965
-2,561
-3% -$7.45K ﹤0.01% 3108
2025
Q1
$238K Sell
73,526
-1,609
-2% -$5.55K ﹤0.01% 3105
2024
Q4
$297K Buy
75,135
+2,660
+4% +$18.1K ﹤0.01% 3109
2024
Q3
$559K Hold
72,475
﹤0.01% 3021
2024
Q2
$371K Hold
72,475
﹤0.01% 3074
2024
Q1
$589K Hold
72,475
﹤0.01% 3016
2023
Q4
$290K Hold
72,475
﹤0.01% 3140
2023
Q3
$298K Sell
72,475
-1,839
-2% -$9.2K ﹤0.01% 3141
2023
Q2
$442K Sell
74,314
-812
-1% -$3.66K ﹤0.01% 3091
2023
Q1
$259K Sell
75,126
-7,272
-9% -$27.1K ﹤0.01% 3155
2022
Q4
$290 Sell
82,398
-3,875
-4% -$13.2K ﹤0.01% 3147
2022
Q3
$312K Sell
86,273
-80,822
-48% -$380K ﹤0.01% 3154
2022
Q2
$941K Buy
167,095
+13,177
+9% +$88.7K ﹤0.01% 2927
2022
Q1
$1.33M Buy
153,918
+51,872
+51% +$520K ﹤0.01% 2924
2021
Q4
$1.14M Buy
102,046
+66,713
+189% +$868K ﹤0.01% 3001
2021
Q3
$458K Buy
35,333
+9,554
+37% +$152K ﹤0.01% 3204
2021
Q2
$427K Sell
25,779
-1,637
-6% -$27.8K ﹤0.01% 3195
2021
Q1
$471K Hold
27,416
﹤0.01% 3153
2020
Q4
$429K Hold
27,416
﹤0.01% 3113
2020
Q3
$523K Hold
27,416
﹤0.01% 3052
2020
Q2
$376K Sell
27,416
-9,572
-26% -$135K ﹤0.01% 3125
2020
Q1
$393K Sell
36,988
-8,671
-19% -$141K ﹤0.01% 3098
2019
Q4
$852K Hold
45,659
﹤0.01% 3038
2019
Q3
$478K Hold
45,659
﹤0.01% 3150
2019
Q2
$346K Hold
45,659
﹤0.01% 3248
2019
Q1
$503K Hold
45,659
﹤0.01% 3166
2018
Q4
$232K Hold
45,659
﹤0.01% 3262
2018
Q3
$145K Buy
45,659
+8,049
+21% +$31.4K ﹤0.01% 3335
2018
Q2
$168K Hold
37,610
﹤0.01% 3267
2018
Q1
$201K Buy
37,610
+12,099
+47% +$55.7K ﹤0.01% 3228
2017
Q4
$101K Hold
25,511
﹤0.01% 3278
2017
Q3
$111K Hold
25,511
﹤0.01% 3268
2017
Q2
$120K Buy
+25,511
New +$244K ﹤0.01% 3236

Other funds holding XBIT

Dimensional Fund Advisors's XBIT Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its XBiotech (XBIT) stake by 29% in Q1 2026, selling an estimated $35.4K and leaving 36,053 shares worth $84.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3133.

Dimensional Fund Advisors first reported a position in XBIT in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.33M in Q1 2022. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • Dimensional Fund Advisors held 36,053 shares of XBiotech worth $84.5K as of Q1 2026.
  • Dimensional Fund Advisors sold 14,642 XBiotech shares in Q1 2026, an estimated $35.4K.
  • XBiotech made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3133 holding.
  • Dimensional Fund Advisors first reported a position in XBiotech in Q2 2017 and has held it in 36 quarters since.
  • Dimensional Fund Advisors's XBiotech position peaked at $1.33M in Q1 2022.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.